Published in J Bras Nefrol on December 01, 2011
IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly. Kidney Int (2005) 2.78
Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol (2008) 2.44
Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin. Kidney Int (2005) 2.42
Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis (2006) 2.09
Associations between renal function, volume status and endotoxaemia in chronic kidney disease patients. Nephrol Dial Transplant (2006) 1.90
Left ventricular mass in chronic kidney disease and ESRD. Clin J Am Soc Nephrol (2009) 1.78
The prognostic impact of fluctuating levels of C-reactive protein in Brazilian haemodialysis patients: a prospective study. Nephrol Dial Transplant (2004) 1.62
Association of ethnicity and survival in peritoneal dialysis: a cohort study of incident patients in Brazil. Am J Kidney Dis (2013) 1.51
Sevelamer carbonate reduces inflammation and endotoxemia in an animal model of uremia. Blood Purif (2010) 1.47
Effects of statins on liver cell function and inflammation in septic rats. J Surg Res (2012) 1.43
[Assessment and management of cardiovascular disease in patients with chronic kidney disease]. J Bras Nefrol (2010) 1.41
Geographic and educational factors and risk of the first peritonitis episode in Brazilian Peritoneal Dialysis study (BRAZPD) patients. Clin J Am Soc Nephrol (2011) 1.36
Length of time on peritoneal dialysis and encapsulating peritoneal sclerosis: position paper for ISPD. Perit Dial Int (2009) 1.34
Characteristics and causes of immune dysfunction related to uremia and dialysis. Perit Dial Int (2008) 1.32
Truncal fat mass as a contributor to inflammation in end-stage renal disease. Am J Clin Nutr (2004) 1.30
Mortality, malnutrition, and atherosclerosis in ESRD: what is the role of interleukin-6? Kidney Int Suppl (2002) 1.20
Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem. J Am Soc Nephrol (2003) 1.16
Family income and survival in Brazilian Peritoneal Dialysis Multicenter Study Patients (BRAZPD): time to revisit a myth? Clin J Am Soc Nephrol (2011) 1.12
Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy. J Am Soc Nephrol (2003) 1.09
Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin. Kidney Int (2004) 1.07
Associations between plasma ghrelin levels and body composition in end-stage renal disease: a longitudinal study. Nephrol Dial Transplant (2004) 1.07
Insulin resistance and glucose homeostasis in peritoneal dialysis. Perit Dial Int (2009) 1.01
Development of a formula for estimation of sodium intake from spot urine in people with chronic kidney disease. Nephron Clin Pract (2014) 1.00
Update on interleukin-6 and its role in chronic renal failure. Nephrol Dial Transplant (2003) 0.99
Predictive value of malnutrition markers for mortality in peritoneal dialysis patients. J Ren Nutr (2010) 0.98
Inflammation contributes to low plasma amino acid concentrations in patients with chronic kidney disease. Am J Clin Nutr (2005) 0.96
Impact of cholecalciferol treatment on biomarkers of inflammation and myocardial structure in hemodialysis patients without hyperparathyroidism. J Ren Nutr (2011) 0.94
Peritoneal dialysis in Brazil: twenty-five years of experience in a single center. Perit Dial Int (2009) 0.92
Vascular damage in kidney disease: beyond hypertension. Int J Hypertens (2011) 0.92
Effect of preload reduction by hemodialysis on left atrial volume and echocardiographic Doppler parameters in patients with end-stage renal disease. Am J Cardiol (2004) 0.90
Association among oral health parameters, periodontitis, and its treatment and mortality in patients undergoing hemodialysis. J Periodontol (2013) 0.90
Association between body mass index and body fat in chronic kidney disease stages 3 to 5, hemodialysis, and peritoneal dialysis patients. J Ren Nutr (2008) 0.89
Inflammation, malnutrition and atherosclerosis in end-stage renal disease: a global perspective. Blood Purif (2002) 0.88
Elevated serum 8-oxo-dG in hemodialysis patients: a marker of systemic inflammation? Antioxid Redox Signal (2006) 0.88
A gut feeling on endotoxemia: causes and consequences in chronic kidney disease. Nephron Clin Pract (2010) 0.88
Peritoneal dialysis in the developing world: recommendations from a symposium at the ISPD meeting 2008. Perit Dial Int (2009) 0.88
Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease. Scand J Urol Nephrol (2004) 0.87
Factors contributing to the differences in peritonitis rates between centers and regions. Perit Dial Int (2007) 0.86
Association between vitamin D receptor gene polymorphisms and susceptibility to chronic kidney disease and periodontitis. Blood Purif (2007) 0.86
Hypovitaminosis D is associated with systemic inflammation and concentric myocardial geometric pattern in hemodialysis patients with low iPTH levels. Nephron Clin Pract (2011) 0.84
Oral health in Brazilian patients with chronic renal disease. Rev Med Chil (2008) 0.84
Reduced gene expression of adiponectin in fat tissue from patients with end-stage renal disease. Kidney Int (2004) 0.84
Usefulness of left atrial volume for the differentiation of normal from pseudonormal diastolic function pattern in patients on hemodialysis. J Am Soc Echocardiogr (2007) 0.83
Geography of peritoneal dialysis in Brazil: analysis of a cohort of 5,819 patients (BRAZPD). J Bras Nefrol (2010) 0.83
Malnutrition and inflammation are associated with impaired pulmonary function in patients with chronic kidney disease. Nephrol Dial Transplant (2004) 0.83
Inflammation and the peritoneal membrane: causes and impact on structure and function during peritoneal dialysis. Mediators Inflamm (2012) 0.83
[Echocardiographic alterations in patients with chronic kidney failure undergoing hemodialysis]. Arq Bras Cardiol (2010) 0.83
Burden of disease: prevalence and incidence of ESRD in Latin America. Clin Nephrol (2015) 0.82
The malnutrition and inflammation axis in pediatric patients with chronic kidney disease. Pediatr Nephrol (2007) 0.82
[Prevalence and prognostic impact of diastolic dysfunction in patients with chronic kidney disease on hemodialysis]. Arq Bras Cardiol (2010) 0.81
Peritoneal dialysis in the developing world: lessons from the Sudan. Perit Dial Int (2007) 0.81
IL-8 but not other biomarkers of endothelial damage is associated with disease activity in patients with ankylosing spondylitis without treatment with anti-TNF agents. Rheumatol Int (2013) 0.80
Plasma cysteine/cystine reduction potential correlates with plasma creatinine levels in chronic kidney disease. Blood Purif (2012) 0.80
Leptin, ghrelin, and proinflammatory cytokines: compounds with nutritional impact in chronic kidney disease? Adv Ren Replace Ther (2003) 0.80
The influence of hepatitis C and iron replacement therapy on plasma pentosidine levels in haemodialysis patients. Nephrol Dial Transplant (2004) 0.80
Interleukin-1 gene cluster polymorphisms are associated with nutritional status and inflammation in patients with end-stage renal disease. Blood Purif (2005) 0.80
Similar outcomes of catheters implanted by nephrologists and surgeons: analysis of the Brazilian peritoneal dialysis multicentric study. Semin Dial (2012) 0.80
Increased calcification and protein nitration in arteries of chronic kidney disease patients. Blood Purif (2011) 0.80
Is UCP2 gene polymorphism associated with decreased resting energy expenditure in nondialyzed chronic kidney disease patients? J Ren Nutr (2008) 0.80
Understanding the role of genetic polymorphisms in chronic kidney disease. Pediatr Nephrol (2008) 0.80
Gene polymorphism association studies in dialysis: the nutrition-inflammation axis. Semin Dial (2005) 0.79
Analysis of IL1 gene polymorphisms and transcript levels in periodontal and chronic kidney disease. Cytokine (2012) 0.79
Changes of metabolic and inflammatory markers in HIV infection: glucose, lipids, serum Hs-CRP and myeloperoxidase. Metabolism (2012) 0.79
Analysis of the association of an MMP1 promoter polymorphism and transcript levels with chronic periodontitis and end-stage renal disease in a Brazilian population. Arch Oral Biol (2012) 0.78
Comparative analysis of lipid and glucose metabolism biomarkers in non-diabetic hemodialysis and peritoneal dialysis patients. J Bras Nefrol (2011) 0.78
Association between left atrium enlargement and intradialytic hypotension: role of diastolic dysfunction in the hemodynamic complications during hemodialysis. Echocardiography (2009) 0.78
Association between biomarkers of carbonyl stress with increased systemic inflammatory response in different stages of chronic kidney disease and after renal transplantation. Nephron Clin Pract (2010) 0.78
Insulin resistance is associated with circulating fibrinogen levels in nondiabetic patients receiving peritoneal dialysis. J Ren Nutr (2007) 0.78
Metabolic impact of peritoneal dialysis. Contrib Nephrol (2009) 0.78
Association between inflammatory markers and left atrial enlargement in patients on hemodialysis. Arq Bras Cardiol (2013) 0.78
Inflammation in peritoneal dialysis: a Latin-American perspective. Perit Dial Int (2007) 0.78
Longitudinal changes in health-related quality of life scores in Brazilian incident peritoneal dialysis patients (BRAZPD): socio-economic status not a barrier. Perit Dial Int (2013) 0.78
Periodontal diseases and systemic inflammation. Semin Dial (2012) 0.78
Novel predictors of peritonitis-related outcomes in the BRAZPD cohort. Perit Dial Int (2014) 0.77
The recommendations from the International Society for Peritoneal Dialysis for Peritonitis Treatment: a single-center historical comparison. Adv Perit Dial (2004) 0.77
Impact of baseline health-related quality of life scores on survival of incident patients on peritoneal dialysis: a cohort study. Nephron (2015) 0.77
Increase in BMI over time is associated with fluid overload and signs of wasting in incident peritoneal dialysis patients. J Ren Nutr (2012) 0.76
Interaction of anemia and decrease in renal function on survival of patients with heart failure. Int J Cardiol (2011) 0.76
Back to basics: pitting edema and the optimization of hypertension treatment in incident peritoneal dialysis patients (BRAZPD). PLoS One (2012) 0.76
Brazilian Peritoneal Dialysis Multicenter Study (BRAZPD): from conception to execution of a national peritoneal dialysis reality check. Contrib Nephrol (2012) 0.76
Associations between the CYBA 242C/T and the MPO -463G/A polymorphisms, oxidative stress and cardiovascular disease in chronic kidney disease patients. Blood Purif (2007) 0.76
Saliva urea nitrogen dipstick - a novel bedside diagnostic tool for acute kidney injury. Clin Nephrol (2014) 0.75
Saliva Urea Nitrogen Continuously Reflects Blood Urea Nitrogen after Acute Kidney Injury Diagnosis and Management: Longitudinal Observational Data from a Collaborative, International, Prospective, Multicenter Study. Blood Purif (2016) 0.75
The impact of living donor kidney transplantation on markers of cardiovascular risk in chronic kidney disease patients. Blood Purif (2007) 0.75
Correction: Automated Peritoneal Dialysis Is Associated with Better Survival Rates Compared to Continuous Ambulatory Peritoneal Dialysis: A Propensity Score Matching Analysis. PLoS One (2015) 0.75
Role of Organic Anion Transporters in the Uptake of Protein-Bound Uremic Toxins by Human Endothelial Cells and Monocyte Chemoattractant Protein-1 Expression. J Vasc Res (2017) 0.75
Age dependent impact of estimated glomerular filtration rate on long-term survival after ischaemic stroke. Nephrology (Carlton) (2012) 0.75
Impact of Pre-Dialysis Care on Clinical Outcomes in Peritoneal Dialysis Patients. Am J Nephrol (2016) 0.75
Controlling inflammation in peritoneal dialysis: the role of pd-related factors as potential intervention targets. Perit Dial Int (2007) 0.75
Use of intravascular ultrasonography for the characterization of coronary artery disease in patients with chronic kidney disease. J Bras Nefrol (2011) 0.75
Continuing medical education program in echocardiography. Echocardiography (2009) 0.75
Evaluation of Salt Intake, Urinary Sodium Excretion and Their Relationship to Overhydration in Chronic Kidney Disease Patients. Blood Purif (2015) 0.75
Induction of systemic inflammation and thickening of subepicardiac arteries in an animal model of uremia. J Bras Nefrol (2011) 0.75
Associations between global population health indicators and dialysis variables in the Monitoring Dialysis Outcomes (MONDO) consortium. Blood Purif (2015) 0.75
Acute hyperkalemia in the emergency department: a summary from a Kidney Disease: Improving Global Outcomes conference. Eur J Emerg Med (2020) 0.75
Impact of Renin-Angiotensin Aldosterone System Inhibition on Serum Potassium Levels among Peritoneal Dialysis Patients. Am J Nephrol (2017) 0.75
Evaluation of sub-clinical atherosclerosis and plasma levels of minimally modified LDL in patients with ankylosing spondylitis and its correlation with disease activity. Rev Bras Reumatol (2014) 0.75
Uremic Toxicity-Induced Eryptosis and Monocyte Modulation: The Erythrophagocytosis as a Novel Pathway to Renal Anemia. Blood Purif (2016) 0.75
Gene expression profiling: a 'fishing expedition' in search of dialysis biocompatibility. Blood Purif (2006) 0.75